How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?

BACKGROUND: The aims of this research were to provide a better understanding of the specific evidence needs for assessment of clinical and cost-effectiveness of cell and gene therapies, and to explore the extent that the relevant categories of evidence are considered in health technology assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Drummond, Michael, Ciani, Oriana, Fornaro, Giulia, Jommi, Claudio, Dietrich, Eva Susanne, Espin, Jaime, Mossman, Jean, de Pouvourville, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182681/
https://www.ncbi.nlm.nih.gov/pubmed/37179322
http://dx.doi.org/10.1186/s12913-023-09494-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182681/
https://www.ncbi.nlm.nih.gov/pubmed/37179322
http://dx.doi.org/10.1186/s12913-023-09494-5

Ejemplares similares